Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.

Smith, S.D.; Conrad, C.; Ramharter, M.; Gottlieb, A.B.; Patel, H.; Xu, W.; Riedl, E.; Schuster, C.

doi:10.1016/j.jaad.2020.02.045

Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.

Détails

Télécharger: Integrated safety analysis- Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.pdf (140.99 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0

ID Serval

serval:BIB_3FB5BC8CC849

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.

Périodique

Journal of the American Academy of Dermatology

Auteur⸱e⸱s

Smith S.D., Conrad C., Ramharter M., Gottlieb A.B., Patel H., Xu W., Riedl E., Schuster C.

ISSN

1097-6787 (Electronic)

ISSN-L

0190-9622

Statut éditorial

Publié

Date de publication

07/2020

Peer-reviewed

Oui

Volume

83

Numéro

1

Pages

261-263

Langue

anglais

Notes

Publication types: Letter
Publication Status: ppublish

Mots-clé

Adult, Aged, Antibodies, Monoclonal, Humanized/adverse effects, Clinical Trials as Topic, Dermatologic Agents/adverse effects, Female, Humans, Interleukin-17/antagonists & inhibitors, Interleukin-17/immunology, Male, Middle Aged, Pharmacovigilance, Psoriasis/diagnosis, Psoriasis/drug therapy, Psoriasis/immunology, Severity of Illness Index, Treatment Outcome, Urinary Tract Infections/chemically induced, Urinary Tract Infections/epidemiology, Urinary Tract Infections/immunology, Young Adult

URN

urn:nbn:ch:serval-BIB_3FB5BC8CC8496

OAI-PMH

oai:serval.unil.ch:BIB_3FB5BC8CC849

DOI

10.1016/j.jaad.2020.02.045

Pubmed

32092375

Web of science

000540826700097

Open Access

Oui